Skip to content

Individualized Prevention Strategy for High Risk Patients in Cardiovascular Disease: Prospective Cohort Study (Cardiovascular and Metabolic Disease Etiology Research Center - HIgh Risk Cohort) CMERC-HI

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02003781
Enrollment
4000
Registered
2013-12-06
Start date
2013-10-31
Completion date
2023-10-31
Last updated
2018-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Risk Cardiovascular Disease Patients

Keywords

cardiovascular disease, metabolic disease, high risk, prospective cohort

Brief summary

Set the prospective cohort (CMERC-HI) to study the known and novel etiologies and related factors for predicting clinical outcomes in Korean patients with high risk cardiovascular disease.

Interventions

None listed

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* high risk hypertension patients a. eGFR \> 60 with one of target organ damages b. eGFR \<= 60 * diabetes mellitus with microalbumin ration (AC ratio \>= 30mg/g) * anuric ESRD patients on dialysis * the relatives of acute myocardial infarction patients under 55 years old (men)/ 65 years old (women) * atherosclerotic cardiovascular disease (abdominal aorta diameter ≥3 cm or ankle-brachial index \<0.9, or carotid plaque or carotid intima-media thickness ≥0.9 mm, or asymptomatic old cerebrovascular accident, or \>30% stenosis in at least one major coronary artery) * rheumatoid arthritis patients aged \> 40 years on MTX and steroid therapy * atrial fibrillation patients with CHADS-VASc Score ≥ 1 * kidney transplant recipient at \> 3 months after transplantation

Exclusion criteria

* acute myocardial infarction, acute coronary syndrome patients, symptomatic coronary artery disease or history of these diseases * symptomatic peripheral artery disease, heart failure and history of these diseases * desired life time under 6 months due to non-cardiovascular disease (e.g. cancer, sepsis) * women with pregnancy or on nursing * history of contrast allergy and related side effects * within the first three months after transplantation * acute renal allograft rejection

Design outcomes

Primary

MeasureTime frameDescription
Prognosis of high risk cardiovascular disease10 year after recrutingall-cause mortality, cardiovascular mortality, non-cardiovascular mortality new onset of acute myocardial infarction, acute coronary syndrome, heart failure, stroke, peripheral artery disease, hospitalization for revascularization and these disease

Countries

South Korea

Contacts

Primary ContactSungha Park, MD
shpark0530@yuhs.ac82-2-2228-8455

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026